| A1A1 | A1A2 | A2A2 | A1A2 and A2A2 |
---|---|---|---|---|
All | Â | Â | Â | Â |
Cases, n (%) | 229 (41.9) | 258 (47.1) | 60 (11.0) | 318 (58.1) |
Controls, n (%) | 227 (41.7) | 249 (45.8) | 68 (12.5) | 317 (58.3) |
OR (95% CI)a | 1.0 | 0.95 (0.72–1.24) | 0.77 (0.51–1.20)b | 0.90 (0.70–1.18) |
Menopausal status at diagnosis | Â | Â | Â | Â |
   Premenopausal |  |  |  |  |
Cases, n (%) | 88 (47.1) | 81 (43.3) | 18 (9.6) | 99 (52.9) |
Controls, n (%) | 100 (43.5) | 99 (43.0) | 31 (13.5) | 130 (56.5) |
OR (95% CI)a | 1.0 | 0.88 (0.56–1.36) | 0.66 (0.33–1.29)b | 0.83 (0.55–1.25) |
   Postmenopausal |  |  |  |  |
Cases, n (%) | 141 (39.2) | 177 (49.2) | 42 (11.6) | 219 (60.8) |
Controls, n (%) | 127 (40.4) | 150 (47.8) | 37(11.8) | 187 (59.5) |
OR (95% CI)a | 1.0 | 0.98 (0.68–1.41) | 0.94 (0.53–1.68)b | 0.97 (0.69–1.38) |